NOVO-NORDISK A/S-SPONS ADR (NVO) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:NVO - US6701002056 - ADR
44.97 USD
-2.66 (-5.58%)
45.6 USD
+0.63 (+1.4%)
ChartMill assigns a Buy % Consensus number of 74% to NVO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 66.81. This target is 48.58% above the current price.
NVO was analyzed by 31 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about NVO.
In the previous month the buy percentage consensus was at a similar level.
NVO was analyzed by 31 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | HSBC | Downgrade | Buy -> Hold |
| 2025-10-14 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2025-10-02 | HSBC | Upgrade | Hold -> Buy |
| 2025-09-29 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2025-09-17 | Berenberg | Upgrade | Hold -> Buy |
| 2025-08-19 | TD Cowen | Maintains | Buy -> Buy |
| 2025-08-05 | UBS | Downgrade | Buy -> Neutral |
| 2025-07-31 | HSBC | Downgrade | Buy -> Hold |
| 2025-07-30 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-04-17 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-01-08 | UBS | Upgrade | Sell -> Buy |
| 2024-12-23 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-11-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-10-17 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-08 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-08-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-07-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-25 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-10 | Argus Research | Maintains | Buy -> Buy |
| 2024-04-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-12 | BMO Capital | Initiate | Outperform |
| 2024-04-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
NOVO-NORDISK A/S-SPONS ADR / NVO FAQ
What do analysts expect the price target to be for NOVO-NORDISK A/S-SPONS ADR (NVO)?
31 analysts have analysed NVO and the average price target is 66.81 USD. This implies a price increase of 48.58% is expected in the next year compared to the current price of 44.97.
Can you provide the consensus rating for NOVO-NORDISK A/S-SPONS ADR stock?
The consensus rating for NOVO-NORDISK A/S-SPONS ADR (NVO) is 74.1936 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for NOVO-NORDISK A/S-SPONS ADR stock?
The number of analysts covering NOVO-NORDISK A/S-SPONS ADR (NVO) is 31.